We were formed in 2014 by neuroscience researchers at the Swiss Federal Institute of Technology (EPFL). We are now headquartered at the High Tech Campus in Eindhoven, the Netherlands, with an office in Lausanne, Switzerland and a growing US team based in Boston, Massachusetts.

Recent News

08 Dec 22
Low blood pressure is a major issue for people with spinal cord injury that impacts cardiovascular health and quality of life ARC Therapy resulted in immediate improvement in blood pressure regulation in all study participants
21 Nov 22
EINDHOVEN, the Netherlands, LAUSANNE, Switzerland, and BOSTON, MA USA—November 21, 2022--ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative therapies to restore movement, independence
10 Nov 22
Data from all nine participants in STIMO trial published in Nature Researchers identify specific neurons activated and remodeled by spinal cord stimulation that enable patients to walk
08 Nov 22
Two additional Breakthrough Device Designations granted by U.S. FDA for ARC Therapy Strong financial position with €70 million in cash and cash equivalents as of September 30, 2022, expected to fund operations through year-end 2024

Financial Calendar

More events are coming soon.